Tag: CORPERNICUS

1. Adding carvedilol to the management of patients with severe heart failure (NYHA Class III-IV and LVEF<25%) is associated with a 35% relative risk reduction in mortality. 2. In this patient population, carvedilol is also associated with decreased risk of hospitalization and serious adverse effects, as well as improvement in...